Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report

BACKGROUND: Rituximab is a monoclonal antibody inducing depletion of B lymphocytes and presently approved for the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. Here is the first report of the use of this drug in a case of Cogan's syndrome (CS). CASE PRESENTATION: a 25-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsoni, Jelka G, Laganà, Bruno, Rubino, Pierangela, Zavota, Laura, Bacciu, Salvatore, Mora, Paolo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907322/
https://www.ncbi.nlm.nih.gov/pubmed/20550723
http://dx.doi.org/10.1186/1750-1172-5-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907322/
https://www.ncbi.nlm.nih.gov/pubmed/20550723
http://dx.doi.org/10.1186/1750-1172-5-18

Ejemplares similares